Ranpirnase

N/A

Report date: 2022/11/25 16:34:12

Base Information

Drug NameRanpirnase
Drug Alias NameAmphibian ribonuclease A豹蛙酶Ranpirnase - Tamir BiotechnologyP-30 protein - AlfacellP-30 ribonuclease +[9] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionRibonucleases stimulants
TargetsRibonucleases
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungMesotheliomaPapillomavirus Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandItaly +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTamir Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTamir Biotechnology IncAlfacell Gmbh
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungMesotheliomaPapillomavirus Infections +[5] 

Other Information

ATC CodeN/A
Related LinksN/A